Drug maker Servier announced it's discontinuing development of an oral therapy for Becker and Duchenne MD after disappointing ...
Sarepta will not reopen clinical trial enrollment for Elevidys in Duchenne muscular dystrophy (DMD) and plans to analyze data ...
Adith Thummalapalli navigates life with DMD by finding community through Parent Project Muscular Dystrophy's Adult Advisory ...
Foir National Family Caregivers Month, columnist Robin Stemple gives a shout out to all those who help him remain in his home ...
A developer is investigating why its therapy for improving function in people with Becker muscular dystrophy failed to meet a key trial goal.
Myotonic dystrophy (DM) is a type of muscular dystrophy that causes muscle weakness, wasting, and myotonia, or difficulty relaxing muscles after using them. It can also affect other parts of the body, ...
Facioscapulohumeral muscular dystrophy (FSHD) is a type of muscular dystrophy that mainly causes muscle weakness in the face and upper body. There is no cure for FSHD, but supportive care can help ...
Becker muscular dystrophy (BMD) is a type of muscular dystrophy — a group of genetic diseases characterized by muscle weakness and wasting — that can emerge in childhood or adulthood and mainly ...
Terri is a Duchenne muscular dystrophy and rare disease advocate whose work is deeply rooted in her experience as mother to her son Billy, who lives with Duchenne. For more than two decades, Terri has ...
Emery-Dreifuss muscular dystrophy (EDMD) is a rare form of muscular dystrophy that affects the skeletal muscles (muscles involved in movement) and cardiac muscles (muscles of the heart). Toe-walking ...
A Phase 3 clinical trial testing delpacibart etedesiran (del-desiran), an experimental treatment for myotonic dystrophy type 1 (DM1), failed to hit its main goal. The Phase 3 HARBOR trial (NCT06411288 ...